Cartalax / TB4 / BPC-157
Research-Grade Multi-Peptide Formulation
Tagline: Combinational Peptide Signaling Research
Product Description
Cartalax / TB4 / BPC-157 is a research-grade multi-peptide formulation containing three distinct peptide components supplied as a single lyophilized preparation for laboratory investigation.
This formulation includes:
-
Cartalax – a short tissue-associated peptide bioregulator model
-
Thymosin Beta-4 (TB4) – a 43–amino acid endogenous peptide studied for cytoskeletal interactions
-
BPC-157 – a synthetic pentadecapeptide investigated in peptide signaling models
The combined formulation is designed for controlled experimental research exploring peptide interaction dynamics, structural behavior, intracellular signaling mechanisms, and multi-component peptide systems.
This product is supplied as a single blended research complex, not as separate individual compounds.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Why Researchers Choose This Formulation
-
Multi-peptide research blend in a single vial
-
Combines tissue-associated, cytoskeletal, and signaling peptide classes
-
Suitable for combinational pathway research
-
Lyophilized for stability and controlled reconstitution
-
Documented peptide classes in peer-reviewed literature
-
Designed for controlled laboratory investigation
Important Note
For laboratory and scientific research only. Not for human consumption, diagnostic, or therapeutic use.
